Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable Platelet Rich Derivatives for Orthodontic Canine Retraction
NCT07408895Completed
- Sponsor
- Sana'a University
- Start
- May 2024
- Primary completion
- Sep 2024
- Modality
- Device-based Delivery, Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised trial of platelet-rich plasma and platelet rich fibrin in malocclusion (2 arms), sponsored by Sana'a University. Primary endpoint: Rate of Orthodontic Canine Retraction at 4 months. Started May 2024; status: completed.
02
Drugs
platelet-rich plasmaplatelet rich fibrin
03
Conditions
malocclusion
Beyond the preview
Go deeper on NCT07408895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07408895.